One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Breaking Barriers: Innovations in Gynecologic Cancer TreatmentJune 26, 2023Gynecologic cancers, which include ovarian, uterine, cervical, vaginal, and vulvar cancers, affect thousands of women worldwide. The diagnosis of gynecologic cancer can be devastating, but thanks to o...view
Introduction of Cabin LaboratorySeptember 27, 20221. Definition of Cabin LaboratoryCabin laboratory is used for nucleic acid detection experiments, microorganism detection experiments, biochemical detection experiments, physical and chemical analysis...view
Gene Chip Microarray: Revolutionizing Genomic ResearchApril 2, 2026Gene Chip Microarray is a powerful tool in genomics for studying gene expression and genetic variation. By simultaneously analyzing thousands of genes on a single chip, this technology provides valuab...view
How to Use Fluorescence Calibration SlidesApril 10, 2024As a key tool in biomedical research, the fluorescence characteristics and stability of fluorescence calibration slides are directly related to the accuracy and reliability of experiments. This paper ...view